Provided by Tiger Trade Technology Pte. Ltd.

ATS Corp.

18.26
+0.23001.28%
Post-market: 18.260.00000.00%19:30 EDT
Volume:188.16K
Turnover:3.43M
Market Cap:1.79B
PE:54.31
High:18.39
Open:18.26
Low:17.99
Close:18.03
52wk High:35.82
52wk Low:17.77
Shares:98.13M
Float Shares:74.46M
Volume Ratio:0.81
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3362
EPS(LYR):0.5242
ROE:2.69%
ROA:2.92%
PB:1.42
PE(LYR):34.83

Loading ...

ATS Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 30

ATS Corporation (ATS) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
May 30

Canada Net Change Percentage Gainers & Losers

Dow Jones
·
May 29

ATS Shares Slide on Modest Growth Guidance, Weaker Orders

Dow Jones
·
May 28

ATS Posts F4Q Ebitda Beat but Softer Bookings Point to Cooling Demand -- Market Talk

Dow Jones
·
May 28

Stock Track | ATS Corp. Plummets 11.53% Intraday on Earnings Miss and Weak Revenue Outlook

Stock Track
·
May 28

Stock Track | ATS Corp. Plunges 10.83% in Pre-Market on Earnings Miss and Weak Outlook

Stock Track
·
May 28

ATS 4Q Loss Narrows as Consumer Products, Energy Drive Revenue Growth

Dow Jones
·
May 28

ATS Fiscal Q4 Adjusted Earnings Fall, Revenue Rises; Fiscal Q1 Sales Outlook Set

MT Newswires Live
·
May 28

ATS Corporation reports Q4 adjusted EPS 36c, consensus 32c

TIPRANKS
·
May 28

GUIDANCE: (ATS) ATS Expects Fiscal Q1 Revenue Range CA$700M to CA$740M

MT Newswires Live
·
May 28

Earnings Flash (ATS) ATS Posts Fiscal Q4 Revenue CA$747.1M

MT Newswires Live
·
May 28

ATS Q4 Adj. EPS $0.36 Beats $0.32 Estimate, Sales $744.300M Beat $546.610M Estimate

Benzinga Earnings
·
May 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 28

Press Release: ATS Reports Fourth Quarter Fiscal 2026 Results

Dow Jones
·
May 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 26

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 22

Earning Preview: ATS Corp. this quarter’s revenue is expected to increase by 6.68%, and institutional views are bullish

Earnings Agent
·
May 21

MiNK Therapeutics reports new data on agenT-797 at ATS 2026

TIPRANKS
·
May 20

MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications

GlobeNewswire
·
May 20